BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  Merrimack Pharmaceuticals Inc. Reports Second Quarter 2014 Financial Results

  August 11, 2014

   · 

  7 min read
• Drug Development

  Mirati Therapeutics Receives Orphan Designation From U.S. FDA For Mocetinostat In Diffuse Large B-Cell Lymphoma

  August 11, 2014

   · 

  4 min read
• Business

  Repligen Corporation Reports Second Quarter 2014 Financial Results

  August 11, 2014

   · 

  13 min read
• Business

  Alcobra Announces Second Quarter Financial Results And Provides Corporate Update

  August 11, 2014

   · 

  8 min read
• Drug Development

  Northwest Biotherapeutics Provides Update About Phase 3 Dcvax®-L Trial For Gbm And “Information Arm” Compassionate Use Patients

  August 11, 2014

   · 

  5 min read
• Business

  Hemispherx Biopharma Announces Financial Results For The Six Months Ended June 30, 2014

  August 11, 2014

   · 

  6 min read
• Business

  Immunomedics, Inc. Announces Conference Call And Webcast For Fourth Quarter And Fiscal Year 2014 Financial Results

  August 11, 2014

   · 

  4 min read
• Drug Development

  Northwest Biotherapeutics Obtains Approvals For Enhancements Of Phase 3 Trial Of Dcvax®-L For Gbm Brain Cancer

  August 11, 2014

   · 

  8 min read
• Business

  MannKind Corporation Reports 2014 Second Quarter Financial Results

  August 11, 2014

   · 

  7 min read
• Business

  Ultragenyx Pharmaceuticals Reports Second Quarter 2014 Financial Results And Corporate Update

  August 11, 2014

   · 

  10 min read